J-Y Delattre
Overview
Explore the profile of J-Y Delattre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dudoit T, Balossier A, Reyes-Botero G, Laigle-Donadey F, Emery E, Blond S, et al.
Rev Neurol (Paris)
. 2021 Jul;
177(10):1276-1282.
PMID: 34272066
Object: Adult brainstem gliomas are a rare group of heterogeneous brain tumors. Classical clinical presentation includes progressive impairment of cranial nerves associated with long tract signs. The prognosis and response...
2.
Terziev R, Petrirena G, Marie Y, Mueller W, Bielle F, Delattre J
Rev Neurol (Paris)
. 2018 Oct;
174(10):705-710.
PMID: 30314742
Objective/background: Posterior fossa (PF) recurrences of supratentorial (ST) World Health Organization (WHO) grade II and III gliomas are thought to be rare and to have grim prognoses. Methods: This study...
3.
4.
5.
Bompaire F, Zinchenko L, Lahutte M, Mokhtari K, Psimaras D, Gaultier C, et al.
Rev Neurol (Paris)
. 2016 Dec;
173(1-2):67-73.
PMID: 27919464
Background: Stroke-like migraine attacks after radiation therapy (SMART) syndrome is a rare complication of cerebral radiation therapy that usually presents>10 years after treatment as reversible paroxysmal episodes of neurological dysfunction...
6.
7.
Mazzocco P, Barthelemy C, Kaloshi G, Lavielle M, Ricard D, Idbaih A, et al.
CPT Pharmacometrics Syst Pharmacol
. 2016 Feb;
4(12):728-37.
PMID: 26904387
Both molecular profiling of tumors and longitudinal tumor size data modeling are relevant strategies to predict cancer patients' response to treatment. Herein we propose a model of tumor growth inhibition...
8.
Delattre J, Dehais C, Ducray F, Figarella-Branger D
Rev Neurol (Paris)
. 2014 Dec;
170(11):643-5.
PMID: 25455381
No abstract available.
9.
Labussiere M, Di Stefano A, Gleize V, Boisselier B, Giry M, Mangesius S, et al.
Br J Cancer
. 2014 Oct;
111(10):2024-32.
PMID: 25314060
Background: The role of telomerase reverse transcriptase (TERT) in gliomagenesis has been recently further strengthened by the frequent occurrence of TERT promoter mutations (TERTp-mut) in gliomas and evidence that the...
10.
Ducray F, Demarquay G, Graus F, Decullier E, Antoine J, Giometto B, et al.
Eur J Neurol
. 2014 Jan;
21(5):731-5.
PMID: 24471811
Background And Purpose: To describe the characteristics of patients presenting a paraneoplastic cerebellar degeneration without classical onconeural antibodies (seronegative PCD). Methods: Thirty-nine seronegative PCD patients from the Paraneoplastic Neurological Syndrome...